AusperBio is a clinical-stage biopharmaceutical company with operations in the USA and China, dedicated to advancing oligonucleotide and targeted delivery technologies for transformative therapies, with an initial focus on curing chronic hepatitis B. The company has developed a proprietary Med-OligoTM ASO platform with novel insights into ASO design and capabilities to substantially enhance the current ASO therapeutics. Combining with efficient targeted delivery conjugation technologies, the modular Med-OligosTM Platform empowers ASO therapeutics to treat broad viral infections, metabolic conditions, genetic disorders, and immune diseases.

Biotechnology

Clinical Trials

Pharmaceutical

Therapeutics

AusperBio

AusperBio's headquarters in San Mateo, United States

AusperBio

Org chart

Teams

Offices

AusperBio

Org chart

Teams

Offices

Related companies